The identification of apolipoprotein genes in rare minnow (Gobiocypris rarus) and their expression following perfluorooctanoic acid exposure

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 151, Issue 1, 2010, Pages 152-159

  Fang, Xuemei ^a,b   Wei, Yanhong ^a   Liu, Yang ^a   Wang, Jianshe ^a   Dai, Jiayin ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Suzhou Teachers' College   (China)

Author keywords

Apolipoprotein; HNF ; PFOA; PPAR; Rare minnow

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; APOLIPOPROTEIN L; APOLIPOPROTEIN M; APOLIPOPROTEIN O; COMPLEMENTARY DNA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYPRINIFORMES; DNA SEQUENCE; DOWN REGULATION; FISH; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; HISTOPATHOLOGY; LIPID METABOLISM; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PRIORITY JOURNAL; UPREGULATION;

ANIMALIA; BARBUS; CYPRINIDAE; CYPRINIFORMES; GOBIOCYPRIS RARUS; HEMIBARBUS MYLODON; TELEOSTEI; VERTEBRATA;

EID: 71649096017     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2009.09.008     Document Type: Article

References (58)

1. Amthauer R., Villanueva J., Vera M.I., Concha M.I., and Krauskopf M. Characterization of the major plasma apolipoproteins of the high density lipoprotein in the carp (Cyprinus carpio). Comp. Biochem. Physiol. B 92 (1989) 787-793
2. Anderson S.P., Dunn C., Laughter A., Yoon L., Swanson C., Stulnig T.M., Steffensen R.K., Chandraratna R.A.S., Gustafsson J.A., and Corton J.C. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol. Pharmacol. 66 (2004) 1440-1452
3. Babin P.J., Thisse C., Durliat M., André M., Akimenko M.A., and Thisse B. Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc. Natl. Acad. Sci. USA 94 (1997) 8622-8627
4. Boon J.P., Oudejans R.C., and Duinker J.C. Kinetics of individual polychlorinated biphenyl (PCB) components in juvenile sole (Solea solea) in relation to their concentrations in food and to lipid metabolism. Comp. Biochem. Physiol. C. 79 (1984) 131-142
5. Chapman M.J. Animal lipoproteins: chemistry, structure, and comparative aspects. J. Lipid Res. 21 (1980) 789-853
6. Christoffersen C., Dahlbäck B., and Nielsen L.B. Apolipoprotein M: progress in understanding its regulation and metabolic functions. Scand. J. Clin. Lab. Invest. 66 (2006) 631-637
7. Concha M.I., Smith V.J., Castro K., Bastias A., Romero A., and Amthauer R.J. Apolipoproteins A-I and A-II are potentially important effectors of innate immunity in the teleost fish Cyprinus carpio. Eur. J. Biochem. 271 (2004) 2984-2990
8. Ding L., Hao F., Shi Z., Wang Y., Zhang H., Tang H., and Dai J. Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies. J. Proteome Res. 8 (2009) 2882-2891
9. Frank P.G., and Marcel Y.L. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 41 (2000) 853-872
10. Gonzalez F.J. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab. Pharmacokinet. 23 (2008) 2-7
11. Handattu S.P., Garber D.W., Monroe C.E., van Groen T., Kadish I., Nayyar G., Cao D., Palgunachari M.N., Li L., and Anantharamaiah G.M. Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease. Neurobiol. Dis. 34 (2009) 525-534
12. Harel A., Fainaru M., Rubinstein M., Tal N., and Schwartz M. Fish apolipoprotein-A-I has heparin binding activity: implication for nerve regeneration. J. Neurochem. 55 (1990) 1237-1243
13. Jang M.H., Lucas M.C., and Joo G.J. The fish fauna of mountain streams in South Korean national parks and its significance to conservation of regional freshwater fish biodiversity. Biol. Conserv. 114 (2003) 115-126
14. Kawakami A., and Yoshida M. Apolipoprotein CIII links dyslipidemia with atherosclerosis. J. Atheroscler. Thromb. 16 (2009) 6-11
15. Kim K.Y., Cho Y.S., Bang I.C., and Nam Y.K. Isolation and characterization of the apolipoprotein multigene family in Hemibarbus mylodon (Teleostei:Cypriniformes). Comp. Biochem. Physiol. B 152 (2009) 38-46
16. Klaunig J.E., Babich M.A., Baetcke K.P., Cook J.C., Corton J.C., David R.M., DeLuca J.G., Lai D.Y., McKee R.H., Peters J.M., Roberts R.A., and Fenner-Crisp P.A. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33 (2003) 655-780
17. Kondo H., Morinaga K., Misaki R., Nakaya M., and Watabe S. Characterization of the pufferfi{ligature}sh Takifugu rubripes apolipoprotein multigene family. Gene 346 (2005) 257-266
18. Krause B.R., Newton R.S., Cutter C.S., Nawrocki J.W., Sandford E.H., and Bressler C.E. Alterations in plasma ApoE and ApoE biosynthesis in gemfibrozil-treated rats. Arteriosclerosis 4 (1984) 521a
19. Lamant M., Smih F., Harmancey R., Philip-Couderc P., Pathak A., Roncalli J., Galinier M., Collet X., Massabuau P., Senard J.M., and Rouet P. ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J. Biol. Chem. 281 (2006) 36289-36302
20. Lange S., Dodds A.W., Gudmundsdóttir S., Bambir S.H., and Magnadóttir B. The ontogenic transcription of complement component C3 and apolipoprotein A-I tRNA in Atlantic cod (Gadus morhua L.)-a role in development and homeostasis?. Dev. Comp. Immunol. 29 (2005) 1065-1077
21. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., and Seed J. Perfl{ligature}uoroalkyl acids: a review of monitoring and toxicological fi{ligature}ndings. Toxicol. Sci. 99 (2007) 366-394
22. Lee J., Scheri R.C., Zhang Y., and Curtis L.R. Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice. Toxicol. Appl. Pharmacol. 233 (2008) 193-202
23. Liu Y., Wang J., Liu Y., Zhang H., Xu M., and Dai J. Expression of a novel cytochrome P450 4 T gene in rare minnow (Gobiocypris rarus) following perfluorooctanoic acid exposure. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 150 (2009) 57-64
24. -{increment}{increment}Ct method. Methods 25 (2001) 402-408
25. Mandard S., Müller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61 (2004) 393-416
26. Magnadottir B. Innate immunity of fish. Fish Shellfish Immunol. 20 (2006) 137-151
27. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
28. Mahley R.W., Innerarity T.L., Rall Jr. S.C., and Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25 (1984) 1277-1294
29. Monajemi H., Fontijn R.D., Pannekoek H., and Horrevoets A.J. The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics. 79 (2002) 539-546
30. Monnot M.J., Babin P.J., Poleo G., Andre M., Laforest L., Ballagny C., and Akimenko M.A. Epidermal expression of apolipoprotein E gene during fin and scale development and fin regeneration in zebrafish. Dev. Dyn. 214 (1999) 207-215
31. Nagasawa M., Hara T., Kashino A., Akasaka Y., Ide T., and Murakami K. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene. Biochem. Pharmacol. (2009) 10.1016/j.bcp
32. Okochi E., Nishimaki-Mogami T., Suzuki K., and Takahashi A. Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes. Biochim. Biophys. Acta 1437 (1999) 393-401
33. Patel S., Drew B.G., Nakhla S., Duffy S.J., Murphy A.J., Barter P.J., Rye K.A., Chin-Dusting J., Hoang A., Sviridov D., Celermajer D.S., and Kingwell B.A. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J. Am. Coll. Cardiol. 53 (2009) 962-971
34. Permadi H., Lundgren B., Andersson K., and DePierre J.W. Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem. Pharmacol. 44 (1992) 1183-1191
35. Plouffe D.A., Hanington P.C., Walsh J.G., Wilson E.C., and Belosevic M. Comparison of select innate immune mechanisms of fish and mammals. Xenotransplantation. 12 (2005) 266-277
36. Raghava, G.P.S. 2002. APSSP2: A combination method for protein secondary structure prediction based on neural network and example based learning. CASP5. A-132.
37. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., and Leonard R.C.J. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. Occup. Environ. Med. 49 (2007) 1086-1096
38. Sana T.R., Janatpour M.J., Sathe M., McEvoy L.M., and McClanahan T.K. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29 (2005) 256-269
39. Sato K., Takahashi Y., Takahashi T., Katoh N., and Akiba Y. Identification of factors regulating lipoprotein lipase catalyzed hydrolysis in rats with the aid of monoacid rich lipoprotein preparations. J. Nutr. Ciochem. 13 (2002) 528-538
40. Schippers E.F., Berbée J.F., van Disseldorp I.M., Versteegh M.I., Havekes L.M., Rensen P.C., and van Dissel J.T. Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery. Intensive Care Med. 34 (2008) 1492-1497
41. Schneider W.J., Nimpf J., and Bujo H. Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr. Opin. Lipidol. 8 (1997) 315-319
42. Smith E.E., and Malik H.S. The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res. 19 (2009) 850-858
43. Staels B., Van Tol A., Andreu T., and Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler Thromb. 12 (1992) 286-294
44. St Clair R.W., and Beisiegel U. What do all the apolipoprotein E receptors do?. Curr. Opin. Lipidol. 8 (1997) 243-245
45. Temel R.E., Trigatti B., DeMattos R.B., Azhar S., Krieger M., and Williams D.L. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc. Natl. Acad. Sci. USA 94 (1997) 13600-13605
46. Tingaud-Sequeira A., Forgue J., André M., and Babin P.J. Epidermal transient down-regulation of retinol-binding protein 4 and mirror expression of apolipoprotein Eb and estrogen receptor 2a during zebrafish fin and scale development. Dev. Dyn. 235 (2006) 3071-3079
47. Tso P., Chen Q., Fujimoto K., Fukagawa K., and Sakata T. Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine. Obes. Res. 3 (1995) 689-695
48. Van Craeyveld E., Lievens J., Jacobs F., Feng Y., Snoeys J., and De Geest B. Apolipoprotein A-I and lecithin: cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions. Gene Ther. (2009) 10.1038/gt. 2009.8
49. Vu-Dac N., Schoonjans K., Laine B., Fruchart J.C., Auwerx J., and Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 269 (1994) 31012-31018
50. Vu-Dac N., Schoonjans K., Kosykh V., Dallongeville J., Fruchart J.C., Staels B., and Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96 (1995) 741-750
51. Wang Y., Zhou L., Li Z., and Gui J.F. Molecular cloning and expression characterization of ApoC-I in the orange-spotted grouper. Fish Physiol. Biochem. 34 (2008) 339-348
52. Wei Y., Liu Y., Wang J., Tao Y., and Dai J. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus). Toxicol. Appl. Pharmacol. 226 (2008) 285-297
53. Xie Y., Yang Q., Nelson B.D., and DePierre J.W. The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice. Biochem. Pharmacol. 66 (2003) 749-756
54. Xie X.F., Liao H.L., Dang H.X., Pang W., Guan Y.F., Wang X., Shyy J.Y.J., Zhu Y., and Sladek F.M. Down-regulation of hepatic HNF4 gene expression during hyperinsulinemia via SREBPs. Mol. Endocrinol. 23 (2009) 434-443
55. Xu S., Laccotripe M., Huang X., Rigott A., Zannis V.I., and Krieger M. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38 (1997) 1289-1298
56. Yue L., and Mazzone T. Peroxisome proliferator-activated receptor gamma stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway. J. Biol. Chem. 284 (2009) 10453-10461
57. Zhou Y., Cheng S., Hu W., and Sun M. A new toxicity test organism-Gobiocypris rarus. Zool. Res. 16 (1995) 59-63
58. Zhou L., Wang Y., Yao B., Li C.J., Ji G.D., and Gui J.F. Molecular cloning and expression pattern of 14 kDa apolipoprotein in orange-spotted grouper, Epinephelus coioides. Comp. Biochem. Physiol. B 142 (2005) 432-437